Scientific reports

Life sciences

journal of clinical medicine

Medicina (Kaunas, Lithuania)

journal of thrombosis and thrombolysis

archives of plastic surgery

journal of hepatology

Journal of thrombosis and haemostasis : JTH

clinical microbiology and infection : the official publication of the european society of clinical microbiology and infectious diseases

th open : companion journal to thrombosis and haemostasis

clinical lymphoma, myeloma & leukemia

research and practice in thrombosis and haemostasis

clinical hemorheology and microcirculation

Materials today. Bio

[1] Von Willebrand factor delays liver repair after acetaminophen-induced acute liver injury in mice.

[2] A new emerging serotype of Vibrio parahaemolyticus in China is rapidly becoming the main epidemic strain.

[3] The Metabolites of the Dietary Flavonoid Quercetin Possess Potent Antithrombotic Activity, and Interact with Aspirin to Enhance Antiplatelet Effects.

[4] Artificial intelligence for morphology-based function prediction in neovascular age-related macular degeneration.

[5] Hemostatic complications associated with ventricular assist devices.

[6] Free flap thrombosis in patients with hypercoagulability: A systematic review.

[7] Elevated White Blood Cell Levels and Thrombotic Events in Patients With Polycythemia Vera: A Real-World Analysis of Veterans Health Administration Data.

[8] Reducing length of stay with the direct oral anti-coagulants in low and intermediate risk pulmonary embolism: a single center experience.

[9] Haematological, biochemical and inflammatory parameters in inactive Behçet's disease. Its association with red blood cell distribution width.

[10] editorial: neuro-development and psychological issues in congenital heart defects

[11] fragment-based lead generation of 5-phenyl-1h-pyrazole-3-carboxamide derivatives as leads for potent factor xia inhibitors

[12] ectonucleoside triphosphate diphosphohydrolase-1/cd39 affects the response to adp of female rat platelets

[13] anti-phosphatidylserine-prothrombin antibodies are associated with outcome in a tia cohort

[14] prevention and treatment ofvenous thromboembolism. case report

[15] the marine-derived triterpenoid frondoside a inhibits thrombus formation

[16] severe renal vascular hypertension caused by upper left branch renal artery stenosis complicated with multiple thrombosis and cardiac hypertrophy

[17] uso de rtpa e aspirina no tratamento de trombose intracardíaca em recém-nascido combined rtpa and aspirin therapy for intracardiac thrombosis in neonates

[18] pure conventional laparoscopic radical nephrectomy with level ii vena cava tumor thrombectomy

[19] surgical treatment of postoperative complications in patients with atherosclerosis of aorta and low extremities' arteries

[20] the marine-derived kinase inhibitor fascaplysin exerts anti-thrombotic activity

[21] extensive and progressive cerebral infarction after infection

[22] is there an increased risk for ischemic stroke in patients with multiple sclerosis, and if so, should preventive treatment be considered?

[23] hughes-stovin syndrome: a rare cause of hemoptysis

[24] transarterial chemoembolization in unresectable hepatocellular carcinoma with portal vein thrombosis: a perspective on survival

[25] deregulated levels of the nf-κb1, nf-κb2, and rel genes in ukrainian patients with leukemia and lymphoma in the post-chernobyl period

[26] trombosis del seno sagital en un neonato

[27] novel anthranilamide-based fxa inhibitors: drug design, synthesis and biological evaluation

[28] paget - schroetter syndrome in athletes (primary effort thrombosis)

[29] Pulmonary embolism at autopsy in cancer patients.

[30] Taurolidine Lock Solutions for the Prevention of Catheter-Related Bloodstream Infections: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

[31] Taurolidine Lock Solutions for the Prevention of Catheter-Related Bloodstream Infections: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

[32] A Prospective Study to Evaluate the Effectiveness of Edoxaban for the Resolution of Left Atrial Thrombosis in Patients with Atrial Fibrillation.

[33] Thermally responsive hydrogel for atrial fibrillation related stroke prevention.

[34] Are Three Weeks of Oral Anticoagulation Sufficient for Safe Cardioversion in Atrial Fibrillation?

[35] Long-term effect of SARS-CoV-2 infection on cardiovascular outcomes and all-cause mortality.

[36] Severe acute myocardial infarction and peripheral thrombosis in patient with bladder cancer

[37] Recurrent Thrombosis With Direct Oral Anticoagulants in Antiphospholipid Syndrome: A Systematic Literature Review and Meta-analysis.

[38] Analysis of recanalization of deep venous thrombosis: a comparative study of patients treated with warfarin vs. rivaroxaban.

[39] Efficacy and Safety of Direct Oral Anticoagulants for Secondary Prevention of Cancer-Associated Thrombosis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials and Prospective Cohort Studies.

[40] Streptococcus group C meningitis with cavernous sinus thrombosis

[41] Impact of rivaroxaban on stent thrombosis and secondary prevention of cardiovascular events in acute coronary syndrome

[42] Streptococcus group C meningitis with cavernous sinus thrombosis

[43] Impact of rivaroxaban on stent thrombosis and secondary prevention of cardiovascular events in acute coronary syndrome

[44] Direct Oral Anticoagulants and Cancer-Associated Thrombosis Management. Where Do We Stand in 2019?

[45] Early Detection of Pump Thrombosis in Patients With Left Ventricular Assist Device.

[46] Neonatal Cerebral Sinovenous Thrombosis

[47] Left Ventricle Assist Device Inflow Cannula Insertion Depth Influences Thrombosis Risk.

[48] A Diagnostic Prediction Model of Acute Symptomatic Portal Vein Thrombosis.

[49] Ex vivo properties of plasma clot formation and lysis in patients with cancer at risk for venous thromboembolism, arterial thrombosis, and death.

[50] Sudden Bilateral Sensorineural Hearing Loss Secondary to Cerebral Venous Thrombosis

[51] Using Artificial Intelligence to Manage Thrombosis Research, Diagnosis, and Clinical Management.

[52] Prevention of deep vein thrombosis in orthopedic surgery.

[53] Risk factors for early-onset seizures in patients with cerebral venous sinus thrombosis: A meta-analysis of observational studies.

[54] Bilateral Transverse Sinus Thrombosis following Craniotomy and Cranial Reconstruction for Sagittal Craniosynostosis.

[55] Torsion of a wandering spleen associated with portal vein thrombosis.

[56] Thrombosis in the Philadelphia Chromosome-Negative Myeloproliferative Neoplasms.

[57] Portal vein variation and thrombosis in right lobe living donor liver transplantation

[58] Free flap thrombosis in patients with hypercoagulability: A systematic review.

[59] Otogenic Lateral Sinus Thrombosis: A Review of Fifteen Patients and Changing Trends in the Management.

[60] Otogenic Lateral Sinus Thrombosis: A Review of Fifteen Patients and Changing Trends in the Management

[61] Chronic thromboembolic pulmonary hypertension from synchronous idiopathic upper extremity deep vein thrombosis and pulmonary embolism.

[62] Portal Vein Thrombosis a Rare but Life-threatening Complication after Laparoscopic Sleeve Gastrectomy: A 5 Years Study in a Bariatric Center of Excellence

[63] Cost-effectiveness analysis of low-dose direct oral anticoagulant (DOAC) for the prevention of cancer-associated thrombosis in the United States.

[64] Line Associated Thrombosis in Pediatric Patients With NF-κB Pathway Variants.

[65] Diagnostic accuracy of three ultrasonography strategies for deep vein thrombosis of the lower extremity: A systematic review and meta-analysis.

[66] Spontaneous Thrombosis of Giant Dissecting Fusiform Middle Cerebral Aneurysm After Double-Barrel Superficial Temporal Artery–Middle Cerebral Artery Bypass: A Case Report of Decision-Making in a Limited Resource Environment

[67] The Clots in Legs Or sTockings after Stroke (CLOTS) 3 trial: a randomised controlled trial to determine whether or not intermittent pneumatic compression reduces the risk of post-stroke deep vein thrombosis and to estimate its cost-effectiveness.

[68] Venous thrombosis and arteriosclerosis obliterans of lower extremities in a very severe patient with 2019 novel coronavirus disease: a case report.

[69] The effect of hydroxychloroquine on thrombosis prevention and antiphospholipid antibody levels in primary antiphospholipid syndrome: A pilot open label randomized prospective study

[70] Left Ventricular Thrombosis: New Perspectives on an Old Problem.

[71] Traumatic thrombosis of intracranial arteries and extensive necrosis of the brain developed during reanimation

[72] How to Differentiate Recurrent Deep Vein Thrombosis from Postthrombotic Syndrome

[73] Deep vein thrombosis associated with factor V inhibitor followed by immune thrombocytopenia

[74] deep vein thrombosis as initial manifestation of whipple disease

[75] lower fxii activity and thrombosis: a comment

[76] serratia marcescens sepsis in a child with deep venous thrombosis – a case report

[77] alterações parenquimatosas na trombose venosa cerebral: aspectos da ressonância magnética e da angiorressonância parenchymal abnormalities in cerebral venous thrombosis: findings of magnetic resonance imaging and magnetic resonance angiography

[78] incidental detection of internal jugular vein thrombosis secondary to undiagnosed benign substernal goiter

[79] a case of upper left extremity deep vein thrombosis with right side middle lobe syndrome

[80] acute bilateral renal vein thrombosis secondary to sepsis from pyelonephritis

[81] a case of acute myeloid leukemia presenting with deep venous thrombosis

[82] platelet activation and stent thrombosis

[83] an integrative thrombosis network: visualization and topological analysis

[84] metastatic carcinoma of unknown primary presenting as jugular venous thrombosis

[85] superior sagittal sinus thrombosis complicating typhoid fever in a teenager

[86] establishment of inferior vena cava thrombosis model in nude mice

[87] the effect of intravascular ultrasound usage for the implantation of drug-eluting stent on the rate of acute thrombosis and restenosis

[88] sagittal venous sinus thrombosis after cesarean section: a case report

[89] caudal vena cava thrombosis in a dairy cow (bos taurus) in argentina

[90] deep cerebral venous thrombosis: a challenging diagnosis

[91] resistance to acetylsalicylic acid and prevalence of thrombosis in patients with stable angina

[92] a rare case of lateral sinus thrombosis with carotid space abscess

[93] peripartum isolated cortical vein thrombosis in a mother with postdural puncture headache treated with an epidural blood patch

[94] severe renal vascular hypertension caused by upper left branch renal artery stenosis complicated with multiple thrombosis and cardiac hypertrophy

[95] cerebral venous thrombosis after a cesarean delivery

[96] improved vascular healing after the successful treatment of very late sirolimus-eluting stent thrombosis with a bare metal stent implantation – a serial optical coherence tomography study

[97] hand knitting induced thrombosis of the subclavian vein in a young woman: an unusual cause of paget-schoetter syndrome

[98] uso de rtpa e aspirina no tratamento de trombose intracardíaca em recém-nascido combined rtpa and aspirin therapy for intracardiac thrombosis in neonates

[99] a unique case of thrombosis in behçet′s disease with methylene tetrahydrofolate reductase homozygous polymorphism and raised homocysteine levels

[100] role of factor xa inhibitors in cancer-associated thrombosis: any new data?

[101] facial ulcerations due to acinetobacter baumannii: vessel thrombosis with bacterial mycelia